Profil
Oliver Pötz is the founder of Signatope GmbH, where he currently holds the title of Chief Executive & Scientific Officer.
The company was founded in 2016.
Postes actifs de Oliver Pötz
| Sociétés | Poste | Début |
|---|---|---|
Signatope GmbH
 Signatope GmbH Pharmaceuticals: MajorHealth Technology Signatope GmbH develops pharmaceutical products. The firm provides assay and antibody development services. Its products include SIGNATOX and SIGNAXENO. The company was founded by Oliver Pötz, Hannes Planatscher, THomas Joos and Octavian Schatz on August 5, 2016 and is headquartered in Reutlingen, Germany. | Directeur Général | 05/08/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Signatope GmbH
Signatope GmbH Pharmaceuticals: MajorHealth Technology Signatope GmbH develops pharmaceutical products. The firm provides assay and antibody development services. Its products include SIGNATOX and SIGNAXENO. The company was founded by Oliver Pötz, Hannes Planatscher, THomas Joos and Octavian Schatz on August 5, 2016 and is headquartered in Reutlingen, Germany. | Health Technology |
